» Articles » PMID: 27508199

State-of-the-art Cross-sectional Liver Imaging: Beyond Lesion Detection and Characterization

Overview
Date 2016 Aug 11
PMID 27508199
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Cross-sectional imaging with computed tomography or magnetic resonance imaging is routinely used to detect and diagnose liver lesions; however, these examinations can provide additional important information. The improvement of equipment and techniques has allowed outstanding evaluation of the vascular and biliary anatomy, which is practicable in most routine examinations. Anatomical variants may exclude patients from certain therapeutic options and may be the cause of morbidity or mortality after surgery or interventional procedures. Diffuse liver disease, such as steatosis, hemochromatosis, or fibrosis, must be diagnosed and quantified. Usually these conditions are silent until the late stages, and imaging plays an important role in detecting them early. Additionally, a background of diffuse disease may interfere in a focal lesion systematic reasoning. The diagnostic probability of a particular nodule varies according to the background liver disease. Nowadays, most diffuse liver diseases can be easily and accurately quantified by imaging, which has allowed better understanding of these diseases and improved patient management. Finally, cross-sectional imaging can calculate total and partial liver volumes and estimate the future liver remnant after hepatectomy. This information helps to select patients for portal vein embolization and reduces postoperative complications. Use of a specific hepatic contrast agent on magnetic resonance imaging, in addition to improving detection and characterization of focal lesions, provides functional global and segmental information about the liver parenchyma.

Citing Articles

Machine learning-based identification of contrast-enhancement phase of computed tomography scans.

Guha S, Ibrahim A, Wu Q, Geng P, Chou Y, Yang H PLoS One. 2024; 19(2):e0294581.

PMID: 38306329 PMC: 10836663. DOI: 10.1371/journal.pone.0294581.


Liver involvement in patients with COVID-19 infection: A comprehensive overview of diagnostic imaging features.

Ippolito D, Maino C, Vernuccio F, Cannella R, Inchingolo R, Dezio M World J Gastroenterol. 2023; 29(5):834-850.

PMID: 36816623 PMC: 9932422. DOI: 10.3748/wjg.v29.i5.834.


Hsa_circ_0072765 knockdown inhibits proliferation, activation and migration in transforming growth factor-beta (TGF-β)-induced hepatic stellate cells (HSCs) by the miR-197-3p/TRPV3 axis.

Jin Y, Guo X, Zhang R, Yan C Histol Histopathol. 2023; 38(11):1295-1306.

PMID: 36714978 DOI: 10.14670/HH-18-586.


A Computed Tomography Nomogram for Assessing the Malignancy Risk of Focal Liver Lesions in Patients With Cirrhosis: A Preliminary Study.

Wu H, Wang Z, Liang Y, Tan C, Wei X, Zhang W Front Oncol. 2022; 11:681489.

PMID: 35127463 PMC: 8814623. DOI: 10.3389/fonc.2021.681489.


MiR-130a-3p Alleviates Liver Fibrosis by Suppressing HSCs Activation and Skewing Macrophage to Ly6C Phenotype.

Liu L, Wang P, Wang Y, Zhang Y, Li C, Yang Z Front Immunol. 2021; 12:696069.

PMID: 34421906 PMC: 8375151. DOI: 10.3389/fimmu.2021.696069.


References
1.
Silva A, Morse B, Hara A, Paden R, Hongo N, Pavlicek W . Dual-energy (spectral) CT: applications in abdominal imaging. Radiographics. 2011; 31(4):1031-46. DOI: 10.1148/rg.314105159. View

2.
Reeder S, McKenzie C, Pineda A, Yu H, Shimakawa A, Brau A . Water-fat separation with IDEAL gradient-echo imaging. J Magn Reson Imaging. 2007; 25(3):644-52. DOI: 10.1002/jmri.20831. View

3.
Wibmer A, Prusa A, Nolz R, Gruenberger T, Schindl M, Ba-Ssalamah A . Liver failure after major liver resection: risk assessment by using preoperative Gadoxetic acid-enhanced 3-T MR imaging. Radiology. 2013; 269(3):777-86. DOI: 10.1148/radiol.13130210. View

4.
Hyodo T, Kumano S, Kushihata F, Okada M, Hirata M, Tsuda T . CT and MR cholangiography: advantages and pitfalls in perioperative evaluation of biliary tree. Br J Radiol. 2012; 85(1015):887-96. PMC: 3474084. DOI: 10.1259/bjr/21209407. View

5.
Sanuki N, Takeda A, Oku Y, Eriguchi T, Nishimura S, Aoki Y . Threshold doses for focal liver reaction after stereotactic ablative body radiation therapy for small hepatocellular carcinoma depend on liver function: evaluation on magnetic resonance imaging with Gd-EOB-DTPA. Int J Radiat Oncol Biol Phys. 2014; 88(2):306-11. DOI: 10.1016/j.ijrobp.2013.10.045. View